From Name:
From Email:
To Name:
To Email:

Optional Message:


Stem cell therapy benefits patients with severe inflammation, trial data show

from COPD News Today

Remestemcel-L, Mesoblast’s lead candidate stem cell therapy for inflammatory diseases, improves lung function and exercise capacity in people with chronic obstructive pulmonary disease and a high degree of inflammation, data from a post-hoc analysis of a Phase 2 trial show. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063